+91-8668442535

Oral Thin Film Drugs Market By Product (Sublingual Film, Fully Dissolving Buccal Film), By Indication (Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence Tests) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Thin-film drugs have been identified as an alternative to conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa, resulting in a rapid onset of action and improved bioavailability for drugs. The thin oral film is mostly used for geriatric, pediatric, and bedridden patients who are unable to take the solid form of the drug. Rising demand for an efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

The report titled "Global Oral Thin Film Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall oral thin film drug market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on product type and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global oral thin film drugs market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global oral thin film drugs market is studied for the following regional markets:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period of 2015–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global oral thin film drug market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global oral thin film drug market's competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global oral thin film drug market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global oral thin film drugs market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on the type of product, the oral thin film drug market is segmented into:

  • Thin Film Oral
  • Sublingual Film
  • fully dissolving buccal film

Scientists throughout the pharmaceutical industry have been trying to explore thin films as novel drug delivery tools. Thin-film drugs have been identified as an alternative to conventional dosage forms. Based on the type of product, the oral thin film drug market is segmented into sublingual film and fully dissolving buccal film.

The sublingual film held the largest share in the oral thin film drug market due to the ease of consumption and its effectiveness as it provides rapid dissolution of the drug without the intake of water and rapid onset of action when delivered orally. There has been a good acceptance of oral drugs as it rules out the problem of dysphagia, a common problem due to difficulty swallowing in people of all ages, and hence it is anticipated to exhibit a tremendous growth rate during the forecast period of 2017 to 2025.

Based on the type of indication, the oral thin film drug market is segmented into:

  • Migraine
  • Schizophrenia
  • Alzheimer's Disease
  • Nausea and vomiting
  • Opioid Dependence
  • Others

The pharmaceutical industry is focusing its interest on shortening drug development timelines and developing efficient drug delivery platforms. Moreover, there is an increasing demand for efficient drug delivery techniques as well as convenience in the transportation of the drug, which has fueled the oral thin film drug market in the recent past. In terms of indication, the oral thin film drugs market is segmented as migraine, schizophrenia, Alzheimer's disease, eye diseases, nausea and vomiting, opioid dependence, and others. Thin-film oral drugs make it easy to swallow drugs without water, especially for pediatric, geriatric, and neurodegenerative patients, where conventional drug delivery is difficult. Hence, Alzheimer's disease, migraine, and opioid dependence would lead the market in the future.

For the purpose of this study, the global oral thin film drugs market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

For the purpose of this study, the global oral thin film drugs market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America was observed as the largest regional segment in the oral thin film drugs market. The U.S. led the North American oral thin film drug market, accounting for more than 80% of the market share due to advanced technologies used in pharmaceutical research and development for the discovery of novel drug delivery techniques.Moreover, the rising demand for an efficient drug delivery route and its acceptability in the region would further drive the oral thin film drug market in the future. However, favorable regulation, growing awareness among the masses, and the launch of novel products would make the Asia Pacific the fastest-growing geographical region during the forecast period. Moreover, rising target populations in the region and the major contributions of India and China to pharmaceutical development would further benefit the oral thin film drug market in the region.

Frequently Asked Question:

The market for Oral Thin Film Drugs Market is expected to reach USD$ XX Bn in 2025.

The Oral Thin Film Drugs Market is expected to see significant CAGR growth over the coming years, at 8.9%.

The report is forecasted to 2017-2025.

The base year of this report is 2016.

MONOSOL RX,TESA LABTEC GMBH,PFIZER, INC,NOVARTIS AG,WOLTERS KLUWER,SOLVAY,ALLERGAN PLC. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58781
Report Format:   PDF
Pages:   120
Rating:    4.8 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support